Cancer Immunotherapies and Vaccines Is Goal of UC Berkeley-Aduro Biotech Initiative
News
The University of California (UC) Berkeley and Aduro Biotech, Inc. recently announced the launch of a collaborative Immunotherapeutics and Vaccine Research Initiative (IVRI), combining the university’s research capacities with the company’s ... Read more